Prosecution Insights
Last updated: November 20, 2026
Application No. 18/775,735

Catheter System

Non-Final OA §103
Filed
Jul 17, 2024
Priority
Jul 19, 2023 — JP 2023-117510
Examiner
STIMPERT, PHILIP EARL
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Terumo Corporation
OA Round
1 (Non-Final)
63%
Grant Probability
Moderate
1-2
OA Rounds
1y 2m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 63% of resolved cases
63%
Career Allowance Rate
571 granted / 902 resolved
-6.7% vs TC avg
Strong +49% interview lift
Without
With
+48.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
53 currently pending
Career history
970
Total Applications
across all art units

Statute-Specific Performance

§101
0.5%
-39.5% vs TC avg
§103
49.3%
+9.3% vs TC avg
§102
19.9%
-20.1% vs TC avg
§112
28.5%
-11.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 902 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1-3 and 6-9 is/are rejected under 35 U.S.C. 103 as being unpatentable over WO 2021/153090 to Harada et al. (Harada hereinafter) in view of US Pre-Grant Publication 2011/0125132 to Krolik et al. (Krolic). Regarding claims 1 and 7, Harada teaches a catheter system (12) configured to be inserted into a body lumen comprising a flexible (see translation page 3, line 25, “flexible polymer materials”) outer tube (30), an inner tube (50) disposed in an inner cavity (54) and movable in an axial direction, a balloon (22) having a tubular shape that connects a distal portion (32) of the outer tube and a distal portion of the inner tube to allow insertion of a rod-like member (70). Harada does not teach a removing unit. Krolik teaches another balloon catheter generally and particularly teaches a removing unit (157, see Figs. 7A-7H showing various embodiments) in the form of a protrusion at an outer peripheral portion of a balloon (150) to remove tissue in the lumen (see e.g. paragraph 186). One of ordinary skill in the art would have found it obvious before the effective filing date of the application to provide a removing unit as taught by Krolik to the balloon of Harada in order to remove obstructive tissue from the vasculature of a patient. Regarding claim 2, Krolik teaches that the removing unit is the protrusion. Regarding claims 3 and 8, Harada teaches an inner tube hub (52) at a proximal end comprising a port (62) for supplying perfusate to an inner part of the inner tube and the balloon. Regarding claims 6 and 9, Harada teaches that the rod-like member is an endoscope (page 6, ln. 19). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to PHILIP E STIMPERT whose telephone number is (571)270-1890. The examiner can normally be reached Monday-Friday, 8a-4p. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Chelsea Stinson can be reached at 571-270-1744. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /PHILIP E STIMPERT/Primary Examiner, Art Unit 3783 2 November 2026
Read full office action

Prosecution Timeline

Jul 17, 2024
Application Filed
Nov 05, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12788436
DEVICES AND METHODS FOR LAPAROSCOPIC ACCESS AND WOUND CLOSURE
3y 11m to grant Granted Nov 10, 2026
Patent 12779105
FLUID MANAGEMENT SYSTEM
4y 5m to grant Granted Nov 03, 2026
Patent 12766305
CLAMP
4y 0m to grant Granted Oct 20, 2026
Patent 12766259
BLOOD GLUCOSE CONTROL SYSTEM AND METHOD
3y 7m to grant Granted Oct 20, 2026
Patent 12752050
INFUSION PUMP
3y 9m to grant Granted Oct 06, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
63%
Grant Probability
99%
With Interview (+48.8%)
3y 6m (~1y 2m remaining)
Median Time to Grant
Low
PTA Risk
Based on 902 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month